Alterity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATHE and other ETFs, options, and stocks.About ATHE
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders.
CEODavid A. Stamler
CEODavid A. Stamler
Employees9
Employees9
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded1997
Founded1997
Employees9
Employees9
ATHE Key Statistics
Market cap63.87M
Market cap63.87M
Price-Earnings ratio-4.42
Price-Earnings ratio-4.42
Dividend yield—
Dividend yield—
Average volume16.71K
Average volume16.71K
High today$3.40
High today$3.40
Low today$3.27
Low today$3.27
Open price$3.39
Open price$3.39
Volume17.04K
Volume17.04K
52 Week high$7.00
52 Week high$7.00
52 Week low$2.04
52 Week low$2.04
Stock Snapshot
With a market cap of 63.87M, Alterity Therapeutics(ATHE) trades at $3.29. The stock has a price-to-earnings ratio of -4.42.
As of 2025-12-13, Alterity Therapeutics(ATHE) stock has fluctuated between $3.27 and $3.40. The current price stands at $3.29, placing the stock +0.6% above today's low and -3.1% off the high.
Alterity Therapeutics(ATHE) shares are trading with a volume of 17.04K, against a daily average of 16.71K.
In the last year, Alterity Therapeutics(ATHE) shares hit a 52-week high of $7.00 and a 52-week low of $2.04.
In the last year, Alterity Therapeutics(ATHE) shares hit a 52-week high of $7.00 and a 52-week low of $2.04.